Biocryst Pharmaceuticals buy Royal Bank of Canada
Start price
05.11.24
/
50%
€6.61
Target price
05.11.25
€9.16
Performance (%)
-6.99%
End price
06.11.25
€6.15
Summary
This prediction ended on 06.11.25 with a price of €6.15. With a performance of -6.99%, the BUY prediction by Royal_Bank_of_Canada finished with a loss. Royal_Bank_of_Canada has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 19.437% | 19.437% | 17.172% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,49 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 13,78 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,71 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 8,88 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $10.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.91
11.04.25
11.04.25
€9.75
11.04.26
11.04.26
40.64%
18:03
18:03
Stopped prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.59
30.01.26
30.01.26
€10.92
30.01.27
30.01.27
48.80%
18:03
18:03
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.60
30.06.25
30.06.25
€11.09
30.06.26
30.06.26
9.34%
18:03
18:03
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€8.90
06.05.25
06.05.25
€11.51
06.05.26
06.05.26
-6.59%
18:03
18:03
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.79
25.02.25
25.02.25
€10.47
25.02.26
25.02.26
-19.06%
26.02.26
26.02.26
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.95
25.09.23
25.09.23
€9.44
25.09.24
25.09.24
-2.42%
26.09.24
26.09.24

